Does Medicaid Pay Too Much for Prescription Drugs? A Case Study of Atypical Anti-Psychotics
Year of publication: |
April 2003
|
---|---|
Authors: | Duggan, Mark G. |
Institutions: | National Bureau of Economic Research (contributor) |
Publisher: |
Cambridge, Mass : National Bureau of Economic Research |
Subject: | Arzneimittel | Pharmaceuticals | Gesetzliche Krankenversicherung | Public health insurance | Gesundheitskosten | Health care costs | Sozialleistungsempfänger | Welfare recipients |
Extent: | 1 Online-Ressource |
---|---|
Series: | NBER working paper series ; no. w9626 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Mode of access: World Wide Web System requirements: Adobe [Acrobat] Reader required for PDF files Hardcopy version available to institutional subscribers. |
Other identifiers: | 10.3386/w9626 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron, (2014)
-
Expansion of medicare benefits to include prescription drugs, June 22, 1993
(1993)
-
Moore, William J., (2007)
- More ...
-
Rauh, Joshua, (2014)
-
Duggan, Mark G., (2021)
-
Duggan, Mark G., (2021)
- More ...